Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 213 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

Heterozygous or Homozygous Familial Hypercholesterolemia Phase 3 Spain
Netherlands
Lebanon
South Africa
United States
Brazil
Germany
Switzerland
Turkey
Israel
Russian Federation
Slovenia
Italy
Norway
Hungary
Canada
Taiwan
France
View All

Long-term Extension Study of Ligelizumab in Food Allergy

Food Allergy Phase 3 France
United States
Spain
Germany
Australia
Canada
Japan
Netherlands
View All

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Chronic Spontaneous Urticaria Phase 3 Turkey
Thailand
Spain
Netherlands
Hong Kong
Malaysia
Canada
United States
Singapore
Poland
View All

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase 2 China

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Macular Polypoidal Choroidal Vasculopathy (PCV) Phase 3 Korea, Republic of

An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain

Major Depressive Disorder Phase 1 United Kingdom

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase 2 China

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP) Phase 3 United States
Turkey
Thailand
Spain
United Kingdom
Italy
Czech Republic
Belgium
Romania
Hungary
France
Australia
China
Germany
Japan
Norway
Hong Kong
Malaysia
Austria
Singapore
Bulgaria
View All

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Primary Immune Thrombocytopenia Phase 3 United States
Turkey
Thailand
Spain
China
Italy
Czech Republic
Romania
Hungary
Japan
Australia
Germany
Norway
Korea, Republic of
Malaysia
Taiwan
Belgium
Austria
United Kingdom
Philippines
Singapore
Netherlands
View All

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Warm Autoimmune Hemolytic Anemia (wAIHA) Phase 3 Italy
Thailand
Spain
France
Romania
Hungary
Germany
China
Japan
Malaysia
United Kingdom
Australia
Singapore
View All